Business Context and Reporting Period
AMN Healthcare Services, Inc. filed this Form 8-K on January 10, 2022, to provide preliminary unaudited consolidated revenue results for the fourth quarter of 2021. The filing supports the company's participation in the 40th Annual J.P. Morgan Healthcare Conference. Full audited financial results for the fourth quarter and fiscal year 2021 are expected to be issued in February 2022.
Key Financial Metrics
- Revenue: Preliminary consolidated revenue for Q4 2021 is expected to be between $1.35 billion and $1.36 billion.
- Operating Margin: Expected to be slightly above the high end of the previously provided guidance range of 11.8% to 12.3%.
- Adjusted EBITDA Margin: Expected to be slightly above the high end of the previously provided guidance range of 15.3% to 15.8%.
- Profit and Cash Flow: The filing text does not provide specific values for net profit, cash flow, debt, or liquidity metrics.
Material Changes Versus Prior Period
The preliminary results exceed prior guidance issued on November 4, 2021. This increase is attributed to strong demand across all revenue segments. Specifically, the Nurse and Allied segment generated approximately $70 million more in labor disruption revenue than was included in the previous guidance.
Guidance, Outlook, and Risks
Management has raised its guidance for both operating margin and adjusted EBITDA margin for the fourth quarter of 2021. The company will discuss operational and financial trends during a presentation on January 11, 2022. The filing includes standard forward-looking statement disclaimers, noting that actual results could differ materially from projections due to variances in revenue accruals, consolidation processes, assessment of accrued liabilities, and expense treatment. The company undertakes no obligation to update these projections except as required by law.
Investor Verification Checklist
- Verify the final audited Q4 2021 revenue and margin figures when released in February 2022.
- Confirm the specific contribution of the Nurse and Allied segment to the $70 million revenue increase.
- Review the reconciliation of adjusted EBITDA margin to GAAP measures in the Q3 2021 press release referenced in the filing.
- Monitor the Q1 2022 revenue outlook to be discussed at the J.P. Morgan Healthcare Conference.